Table 4 Antiproliferative effect of somatostatin analogues in patients with progressive disease.

Lanreotide

3000 mg/day

22

0

1

7

14

[97]

Lanreotide

30 mg/2 weeks

35

0

1

20

14

[90]

Octreotide

600 and 1500 mg/day

52

0

0

19

33

[74]

Octreotide

1500 and 3000 mg/day

58

0

2

27

29

[26]

Lanreotide

15000 mg/day

24

1

1

11

11

[97]

Octreotide

600 mg/day

10

0

0

5

5

[73]

Octreotide

median dose of 250 μg three times daily

34

0

1

17

0

[75]

Octreotide LAR 30/

Lanreotide SR

60 mg/28 days

31

0

0

14

4

[76]

Total

256

1

6

115

105

Percentage

(%)

0.3

2

45

41